You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T Therapies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma:

Completed
  • Diffuse Large B-cell Lymphoma
    • East Hanover, New Jersey
      Novartis
    Jun 16, 2023

    Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma

    Completed
    • Diffuse Large B-cell Lymphoma (DLBCL)
    • CAR-T
    • Allo-HSCT cohort
    • East Hanover, New Jersey
      Novartis Investigative Site
    Jun 29, 2022

    Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in San Francisco (Pembrolizumab)

    Not yet recruiting
    • Multiple Myeloma
    • +4 more
    • Pembrolizumab
    • San Francisco, California
      University of California, San Francisco
    Mar 23, 2022

    Non-Hodgkin Lymphoma, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in United States (radiation,

    Recruiting
    • Non-Hodgkin Lymphoma
    • +2 more
    • Bridging radiotherapy (BRT)
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Jan 24, 2023

    CLL, Chronic Lymphocytic Leukemia Trial in Milano, Torino (Peripheral blood samples withdrawal)

    Recruiting
    • CLL
    • Chronic Lymphocytic Leukemia
    • Peripheral blood samples withdrawal
    • Milano, Italy
    • +1 more
    Jan 3, 2022

    CIBMTR Research Database

    Recruiting
    • Autologous Stem Cell Transplantation
    • +6 more
      • Minneapolis, Minnesota
      • +1 more
      Jan 20, 2023

      Hematologic Malignancy Trial in Bologna

      Recruiting
      • Hematologic Malignancy
        • Bologna, Italy
          Programma Dipartimentale Terapie Cellulari Avanzate
        Apr 17, 2023

        Lymphoma, Leukemia, Plasma Cell Dyscrasia Trial in San Francisco (Web Application)

        Not yet recruiting
        • Lymphoma
        • +2 more
        • Web Application
        • San Francisco, California
          University of California, San Francisco
        Oct 4, 2022

        Multiple Myeloma in Remission Trial in Shenzhen, Haikou (MM-specific universal CAR T cells)

        Recruiting
        • Multiple Myeloma in Remission
        • MM-specific universal CAR T cells
        • Shenzhen, Guangdong, China
        • +1 more
        Aug 23, 2023

        SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

        Recruiting
        • SLE (Systemic Lupus)
        • +4 more
        • CD19 targeted CAR-T cells
        • Taiyuan, Shanxi, China
          Shanxi Bethune Hospital
        Sep 25, 2023

        Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

        Not yet recruiting
        • Multiple Myeloma
        • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
        • +3 more
        • (no location specified)
        Jul 28, 2023

        Refractory Neuroblastoma, Relapsed Neuroblastoma, High-risk Neuroblastoma Trial (GPC2 CAR T cells)

        Not yet recruiting
        • Refractory Neuroblastoma
        • +2 more
        • GPC2 CAR T cells
        • (no location specified)
        Dec 21, 2022

        Safety and Efficacy of TCR-like CAR-T Trial in Nanjing (TCR-like CAR-T)

        Recruiting
        • Safety and Efficacy of TCR-like CAR-T
        • TCR-like CAR-T
        • Nanjing, Jiangsu, China
          Zhongda hospital
        Jul 26, 2023

        Refractory Multiple Myeloma, Relapsed Multiple Myeloma Trial in San Francisco (Manufactured Anti-BCMA CAR-T cells, Fludarabine,

        Recruiting
        • Refractory Multiple Myeloma
        • Relapsed Multiple Myeloma
        • Manufactured Anti-BCMA CAR-T cells
        • +2 more
        • San Francisco, California
          University of California, San Francisco
        Jan 6, 2023

        Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

        Recruiting
        • Multiple Myeloma
        • APRIL-BAFF-Bicephali CAR-T cells
        • Xuzhou, Jiangsu, China
          Kailin Xu
        Nov 14, 2023

        Patients Undergoing CAR-T Cell Therapy (CAR_21_01)

        Recruiting
        • CAR-T Therapy Complications
          • Bologna, Italy
            IRCC, University Hospital of Bologna
          Mar 18, 2022

          Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

          Recruiting
          • Gastric Cancer
          • +6 more
          • CEA CAR-T cells
          • Nanchang, Jiangxi, China
            The First Affiliated Hospital of Nanchang University
          Aug 23, 2023

          Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (Pirtobrutinib, LV20.19 CAR T cells)

          Not yet recruiting
          • Non Hodgkin Lymphoma
          • +5 more
          • (no location specified)
          Aug 4, 2023

          CAR-T Cell Induced Cardiac Dysfunction: A Prospective Study

          Not yet recruiting
          • Lymphoma
          • Chimeric Antigen Receptor
          • (no location specified)
          Oct 24, 2023

          Gastric Cancer, Colon Cancer, Rectal Cancer Trial in Taiyuan (CEA-targeted CAR-T cells)

          Recruiting
          • Gastric Cancer
          • +6 more
          • CEA-targeted CAR-T cells
          • Taiyuan, Shanxi, China
          • +1 more
          Aug 24, 2023

          Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Palo Alto

          Not yet recruiting
          • Multiple Sclerosis
          • +2 more
          • KYV-101 anti-CD19 CAR-T cell therapy
          • Standard lymphodepletion regimen
          • Palo Alto, California
            Stanford Multiple Sclerosis Center
          Nov 13, 2023

          CB-Long-Term Safety Study (CB-LTSS)

          Enrolling by invitation
          • Lymphoma, Non-Hodgkin
          • +7 more
          • Allogeneic CAR-T therapy
          • Irvine, California
          • +3 more
          Nov 18, 2022

          Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

          Recruiting
          • Relapse/Refractory Multiple Myeloma
          • DeepTag-GPRC5D Targeted CAR T-cells
          • Hangzhou, Zhejiang, China
            The first affiliated hospital of medical college of zhejiang uni
          Oct 10, 2023

          Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

          Recruiting
          • Pancreas Cancer
          • +3 more
          • CAR-T cells
          • Guangzhou, Guangdong, China
            The Second Affiliated Hospital of Guangzhou Medical University
          Mar 10, 2023

          Acute Lymphoblastic Leukemia, in Relapse, Acute Lymphoblastic Leukemia With Failed Remission, Acute Lymphoblastic Leukemia

          Recruiting
          • Acute Lymphoblastic Leukemia, in Relapse
          • +5 more
          • CAR-20/19-T cells (1 x 10^5 CAR-20/19-T cells/kg)
          • +4 more
          • Milwaukee, Wisconsin
            Medical College of Wisconsin
          Sep 22, 2022